Medication use and associated health care outcomes and costs for patients with psoriasis in the United States

References

• About Psoriasis – Statistics [Internet]. Portland, OR: National Psoriasis Foundation [cited 2010 February 28]. Available from: http://www.psoriasis.org/netcommunity/learn_statistics.
   Google Scholar
• Psoriasis [Internet]. Bethesda, MD: National Institute of Arthritis and Musculoskeletal and Skin, National Institute of Health [cited 2010 February 28]. Available from: http://www.niams.nih.gov.proxy.lib.umich.edu/Health_Info/Psoriasis/default.asp.
   Google Scholar
• Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003–2004. J Am Acad Dermatol. 2009;60(2):218–224.
   PubMed Web of Science ®Google Scholar
• Treatment of Psoriasis [Internet]. Waltham, MA: UpToDate [cited 2010 March 07]. Available from: http://www.uptodate.com/online/content/topic.do?topicKey=papulos/5539&selectedTitle=1∼150&source=search_result.
   Google Scholar
• Mukhtar R, Choi J, Koo JY. Quality-of-life issues in psoriasis. Dermatol Clin. 2004;22(4):389.
   PubMed Web of Science ®Google Scholar
• Fowler JF, Duh MS, Rovba L, Buteau S, Pinheiro L, Lobo F, The impact of psoriasis on health care costs and patient work loss. J Am Acad Dermatol. 2008;59(5):772–780.
   PubMed Web of Science ®Google Scholar
• Schmitt JM, Ford DE. Work limitations and productivity loss are associated with health-related quality of life but not with clinical severity in patients with psoriasis. Dermatology. 2006;213(2):102–110.
   PubMed Web of Science ®Google Scholar
• Radtke MA, Augustin M. Economic considerations in psoriasis management. Clin Dermatol. 2008;26(5):424–431.
   PubMed Web of Science ®Google Scholar
• Javitz HS, Ward MM, Farber E, Nail L, Vallow SG. The direct cost of care for psoriasis and psoriatic arthritis in the United States. J Am Acad Dermatol. 2002;46(6):850–860.
   PubMed Web of Science ®Google Scholar
• Crown WH, Bresnahan BW, Orsini LS, Kennedy S, Leonardi C. The burden of illness associated with psoriasis: Cost of treatment with systemic therapy and phototherapy in the US. Curr Med Res Opin. 2004;20(12):1929–1936.
   PubMed Web of Science ®Google Scholar
• Yu AP, Tang J, Xie J, Wu EQ, Gupta SR, Bao Y, Economic burden of psoriasis compared to the general population and stratified by disease severity. Curr Med Res Opin. 2009;25(10):2429–2438.
   PubMed Web of Science ®Google Scholar
• Finzi AF, Mantovani LG, Belisari A; Italian Association for Studies on Psoriasis. The cost of hospital-related care of patients with psoriasis in Italy based on the AISP study. Associazione Italiana Studi Psoriasi. J Eur Acad Dermatol Venereol. 2001;15(4):320–324.
   PubMed Web of Science ®Google Scholar
• Melnikova I. Psoriasis market. Nat Rev Drug Discov. 2009;8(10):767–768.
   PubMed Web of Science ®Google Scholar
• Ashcroft DM, Li Wan Po A, Griffiths CE. Therapeutic strategies for psoriasis. J Clin Pharm Ther. 2000;25(1):1–10.
   PubMed Web of Science ®Google Scholar
• Callen JP, Krueger GG, Lebwohl M, McBurney EI, Mease P, Menter A, ; AAD. AAD consensus statement on psoriasis therapies. J Am Acad Dermatol. 2003;49(5):897–899.
   PubMed Web of Science ®Google Scholar
• Baughman RD. A 61-year-old man with psoriasis. JAMA. 1996;276(17):1421–1428.
   PubMed Web of Science ®Google Scholar
• Nast A, Erdmann R, Pathirana D, Rzany B. Translating psoriasis treatment guidelines into clinical practice – the need for educational interventions and strategies for broad dissemination. J Eval Clin Pract. 2008;14(5):803–806.
   PubMed Web of Science ®Google Scholar
• Strowd LC, Yentzer BA, Fleischer AB Jr, Feldman SR. Increasing use of more potent treatments for psoriasis. J Am Acad Dermatol. 2009;60(3):478–481.
   PubMedGoogle Scholar
• Nast A, Spuls PH, Ormerod AD, Reytan N, Saiag PH, Smith CH, A critical appraisal of evidence-based guidelines for the treatment of psoriasis vulgaris: ‘AGREE-ing’ on a common base for European evidence-based psoriasis treatment guidelines. J Eur Acad Dermatol Venereol. 2009;23(7):782–787.
   PubMed Web of Science ®Google Scholar
• Lebwohl M. Psoriasis. Lancet. 2003;361(9364):1197–1204.
   PubMed Web of Science ®Google Scholar
• Lebwohl M, Ting PT, Koo JY. Psoriasis treatment: Traditional therapy. Ann Rheum Dis. 2005;64(suppl 2):ii83–86.
   PubMed Web of Science ®Google Scholar
• Pearce DJ, Stealey KH, Balkrishnan R, Fleischer AB Jr, Feldman SR. Psoriasis treatment in the united states at the end of the 20th century. Int J Dermatol. 2006;45(4):370–374.
   PubMed Web of Science ®Google Scholar
• Schon MP. Advances in psoriasis treatment. Lancet. 2005;366(9494):1333–1335.
   PubMed Web of Science ®Google Scholar
• Feldman SR, Horn EJ, Balkrishnan R, Basra MK, Finlay AY, McCoy D, ; International Psoriasis Council. Psoriasis: Improving adherence to topical therapy. J Am Acad Dermatol. 2008;59(6):1009–1016.
   PubMed Web of Science ®Google Scholar
• Patel V, Horn EJ, Lobosco SJ, Fox KM, Stevens SR, Lebwohl M. Psoriasis treatment patterns: Results of a cross-sectional survey of dermatologists. J Am Acad Dermatol. 2008;58(6):964–969.
   PubMed Web of Science ®Google Scholar
• Winterfield LS, Menter A, Gordon K, Gottlieb A. Psoriasis treatment: Current and emerging directed therapies. Ann Rheum Dis. 2005;64(suppl 2):ii87.
   PubMedGoogle Scholar
• Report on the Psycho-Social Impacts of Psoriasis [Internet]. Portland, OR: National Psoriasis Foundation [cited 2010 February 28]. Available from: http://www.psoriasis.org/NetCommunity/Document.Doc?id=619.
   Google Scholar
• Kimball AB, Jacobson C, Weiss S, Vreeland MG, Wu Y. The psychosocial burden of psoriasis. Am J Clin Dermatol. 2005;6(6):383–392.
   PubMed Web of Science ®Google Scholar
• De Korte J, Sprangers MA, Mombers FM, Bos JD. Quality of life in patients with psoriasis: A systematic literature review. J Investig Dermatol Symp Proc. 2004;9(2):140–147.
   PubMedGoogle Scholar
• Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R. Quality of life in patients with psoriasis. Health Qual Life Outcomes. 2006;4:35.
   PubMed Web of Science ®Google Scholar
• Ashcroft DM, Li Wan Po A, Williams HC, Griffiths CE. Quality of life measures in psoriasis: A critical appraisal of their quality. J Clin Pharm Ther. 1998;23(5):391–398.
   PubMed Web of Science ®Google Scholar
• Mckenna KE, Stern RS. The outcomes movement and new measures of the severity of psoriasis. J Am Acad Dermatol. 1996;34(3):534–538.
   PubMed Web of Science ®Google Scholar
• Kulkarni AS, Balkrishnan R, Richmond D, Pearce DJ, Feldman SR. Medication-related factors affecting health care outcomes and costs for patients with psoriasis in the United States. J Am Acad Dermatol. 2005;52(1):27–31.
   PubMed Web of Science ®Google Scholar
• Benoit S, Hamm H. Childhood psoriasis. Clin Dermatol. 2007;25(6):555–562.
   PubMed Web of Science ®Google Scholar
• Burden AD. Management of psoriasis in childhood. Clin Exp Dermatol. 1999;24(5):341–345.
   PubMed Web of Science ®Google Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–619.
   PubMed Web of Science ®Google Scholar
• D'Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol. 1996;49(12):1429–1433.
   PubMed Web of Science ®Google Scholar
• Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: A longitudinal cohort study. Clin Ther. 2003;25(11):2958–2971.
   PubMed Web of Science ®Google Scholar
• Lee ES, Forthofer RN, Lorimor RJ. Analysis of complex sample survey data: Problems and strategies. Sociological Methods Research. 1986;15(1-2):69.
   Web of Science ®Google Scholar
• Aparasu RR. Autonomous ambulatory care by nurse practitioners and physician assistants in office-based settings. J Allied Health. 2001;30(3):153–159.
   PubMedGoogle Scholar
• Goodwin R, Gould MS, Blanco C, Olfson M. Prescription of psychotropic medications to youths in office-based practice. Psychiatr Serv. 2001;52(8):1081–1087.
   PubMed Web of Science ®Google Scholar
• Sobal J, Rauschenbach B, Frongillo EA. Marital status changes and body weight changes: A US longitudinal analysis. Soc Sci Med. 2003;56(7):1543–1555.
   PubMed Web of Science ®Google Scholar
• Sleath B, Tina Shih Y. Sociological influences on antidepressant prescribing. Soc Sci Med. 2003;56(6):1335–1344.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• Van de Kerkhof PC, Steegers-Theunissen RP, Kuipers MV. Evaluation of topical drug treatment in psoriasis. Dermatology. 1998;197(1):31–36.
   PubMed Web of Science ®Google Scholar
• Callen JP. New psoriasis treatments based upon a deeper understanding of the pathogenesis of psoriasis vulgaris and psoriatic arthritis: A personal appraisal of their use in practice. J Am Acad Dermatol. 2003;49(2):351–356.
   PubMed Web of Science ®Google Scholar
• Kupper TS. Immunologic targets in psoriasis. N Engl J Med. 2003;349(21):1987–1990.
   PubMed Web of Science ®Google Scholar
• Boehncke WH, Prinz J, Gottlieb AB. Biologic therapies for psoriasis. A systematic review. J Rheumatol. 2006;33(7):1447–1451.
   PubMed Web of Science ®Google Scholar